Researchers from the Josep Carreras Leukaemia Research Institute, spearheaded by the Cancer Epigenetics group led by Dr. Manel Esteller, described the effects of chemotherapy at the single cell resolution in the bone marrow of Myelodysplastic Syndrome patients.
Single-cell study reveals clues to epigenetic drug response in Myelodysplastic Syndrome
- Post author:
- Post published:February 6, 2024
- Post category:uncategorized